These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36347425)

  • 1. Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro.
    Gan C; Wang Y; Xiang Z; Liu H; Tan Z; Xie Y; Yao Y; Ouyang L; Gong C; Ye T
    J Adv Res; 2023 Sep; 51():109-120. PubMed ID: 36347425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niclosamide - encapsulated lipid nanoparticles for the reversal of pulmonary fibrosis.
    Yu Y; Liu H; Yuan L; Pan M; Bei Z; Ye T; Qian Z
    Mater Today Bio; 2024 Apr; 25():100980. PubMed ID: 38434573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
    Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
    Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway.
    Pei X; Zheng F; Li Y; Lin Z; Han X; Feng Y; Tian Z; Ren D; Cao K; Li C
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
    Chen YL; Zhang X; Bai J; Gai L; Ye XL; Zhang L; Xu Q; Zhang YX; Xu L; Li HP; Ding X
    Cell Death Dis; 2013 Jun; 4(6):e665. PubMed ID: 23764846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
    Zhu L; Fu X; Chen X; Han X; Dong P
    Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nintedanib solid lipid nanoparticles improve oral bioavailability and ameliorate pulmonary fibrosis in vitro and in vivo models.
    Kaur R; Shaikh TB; Priya Sripadi H; Kuncha M; Vijaya Sarathi UVR; Kulhari H; Balaji Andugulapati S; Sistla R
    Int J Pharm; 2024 Jan; 649():123644. PubMed ID: 38040396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study.
    Gan C; Zhang Q; Liu H; Wang G; Wang L; Li Y; Tan Z; Yin W; Yao Y; Xie Y; Ouyang L; Yu L; Ye T
    Respir Res; 2022 Feb; 23(1):32. PubMed ID: 35172837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway.
    Ruan H; Gao S; Li S; Luan J; Jiang Q; Li X; Yin H; Zhou H; Yang C
    Molecules; 2021 May; 26(9):. PubMed ID: 34068694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
    Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fyn-kinase and caveolin-1 in the alveolar epithelial junctional adherence complex contribute to the early stages of pulmonary fibrosis.
    Menzel V; Ziegler M; Hante N; Sake JA; Santos-Martinez MJ; Ehrhardt C; Kasper M; Barth K
    Eur J Pharm Sci; 2022 Aug; 175():106236. PubMed ID: 35710078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway.
    Miao Y; Li X; Yang Y; Zhang J; Chen L; Zhang Q; Li W; Liu Y; Zhang X; Gu R; Yang C
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109427. PubMed ID: 36375321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.
    Miao Y; Wang Y; Bi Z; Huang K; Gao J; Li X; Li S; Wei L; Zhou H; Yang C
    BMC Pulm Med; 2023 Mar; 23(1):94. PubMed ID: 36949426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
    Deng W; Zhang Y; Fang P; Shi H; Yang S
    Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
    Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
    Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes Activation of Lung Fibroblasts in Pulmonary Fibrosis.
    Zhang W; Ohno S; Steer B; Klee S; Staab-Weijnitz CA; Wagner D; Lehmann M; Stoeger T; Königshoff M; Adler H
    Front Immunol; 2018; 9():1216. PubMed ID: 29910813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
    Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
    Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of the novel Benzo[b]thiophene 1,1-dioxide derivatives as a potent STAT3 inhibitor against idiopathic pulmonary fibrosis.
    Wang Y; Liu H; Li W; Xie Y; Gan C; Xue T; Su X; Yue L; Wang Q; Fan C; Zhang Y; Ye T
    Eur J Med Chem; 2023 Jan; 246():114953. PubMed ID: 36463728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.